|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
WHO007969562 |
003 |
DE-627 |
005 |
20230425181208.0 |
007 |
cr uuu---uuuuu |
008 |
211103s2021 xx |||||o 00| ||eng c |
035 |
|
|
|a (DE-627)WHO007969562
|
035 |
|
|
|a (UBBS_Klinische_Studien_WHO)EUCTR2021-004021-71-NL
|
035 |
|
|
|a (UBBS_Klinische_Studien_WHO)NL.78693.041.21
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
245 |
1 |
0 |
|a Corticosteroids for loss of smell by COVID-19 infection – COCOS trial
|b COrticosteroids for COVID-19 induced loss of Smell – COCOS trial - COCOS trail
|
264 |
|
1 |
|c 2021
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 12-10-2021, Last updated: 2022-11-24
|
650 |
|
4 |
|a Medical Condition: Loss of smell after COVID-19 infection, persisting after 4 weeks;Therapeutic area: Diseases [C] - Ear, nose and throat diseases [C09]
|
650 |
|
4 |
|a Study Type: Interventional
|
650 |
|
4 |
|a Phase: Phase 4
|
650 |
|
4 |
|a Recruitment Status: Authorised-recruitment may be ongoing or finished
|
650 |
|
4 |
|a 610
|
773 |
0 |
8 |
|i Enthalten in
|t WHO International Clinical Trials Registry Platform
|g (2021) vom: 18. Okt.
|
773 |
1 |
8 |
|g year:2021
|g day:18
|g month:10
|
856 |
4 |
0 |
|u https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-004021-71
|z kostenfrei
|3 Volltext
|
912 |
|
|
|a GBV_CTG
|
912 |
|
|
|a SSG-OLC-PHA
|
951 |
|
|
|a AR
|
952 |
|
|
|j 2021
|b 18
|c 10
|